论文部分内容阅读
抗癌复方注射液（220mg生药／kg体重）能显著地同步升高麻醉大鼠的±dp/dtmax、LVSP、SBP、DBP和MAP，缩短t-dp／dtmax，+dp／dtmax比-dp／dtmax上升幅度更大。血压升高时，脉压加大。当±dp／dtmax已明显升高时，心率与给药前无显著差异。抗癌复方注射液（25．8、12．9、6．45μg生药／mL）灌流离体豚鼠心脏，心肌收缩力和冠脉流量均显著增加，灌流10min时，高、中、低浓度心肌收缩力分别增加55．1％、38．4％和20．4％，灌流2min时冠脉流量分别增加36．7％、74．3％和54．8％，灌流后心率无明显变化。抗癌复方注射液（66．2mg生药／kg体重）缓慢静注对麻醉家兔的平均动脉压、心率、心指数和总外周阻力指数无明显影响。
Anti-cancer compound injection (220 mg crude drug/kg body weight) can significantly increase ±dp/dtmax, LVSP, SBP, DBP, and MAP in anesthetized rats, shortening t-dp/dtmax, and +dp/dtmax ratio -dp/ Dtmax increased more. When blood pressure rises, pulse pressure increases. When ±dp/dtmax was significantly increased, there was no significant difference in heart rate from pre-dose. Anti-cancer compound injection (25.8, 12.9, 6.45 μg crude drug/mL) perfused isolated guinea pig heart, myocardial contractility and coronary flow were significantly increased, perfusion 10 min, high, medium and low concentrations of myocardial contraction The force increased by 55.1%, 38.4%, and 20.4%, and the coronary flow increased by 36.7%, 74.3%, and 54.8%, respectively, at 2 minutes of perfusion. There was no significant change in heart rate after perfusion. Slow intravenous injection of anti-cancer compound injection (66.2 mg crude drug/kg body weight) had no significant effect on mean arterial pressure, heart rate, heart index, and total peripheral resistance index of anesthetized rabbits.